DBV Technologies S.A.
VIASKIN Peanut Patch
peanut allergy
Date
TBD
Phase 2 readout · Date TBD estimated
What's at stake
Phase 2 trial results for VIASKIN Peanut Patch in peanut allergy are due Date TBD. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 8-K
verified 13h ago
“The Company plans to initiate a first of its kind study in infants ages 6 through 12 months. This Phase 2 study, previously announced at last year’s American College of Asthma, Allergy, and Immunology, and now called THRIVE, will assess the”